Identification of obstructive sleep apnoea as a novel and potentially treatable risk factor for postoperative de-novo silent and symptomatic atrial fibrillation after elective coronary artery bypass grafting surgery (CONSIDER AF – OBSERVATION)

Postoperativ neu aufgetretenes Vorhofflimmern zählt zu den häufigsten Komplikationen nach herzchirurgischen Eingriffen und ist mit einer erhöhten Morbidität, Mortalität und einer längeren Behandlungsdauer assoziiert. Insbesondere asymptomatische, „stille“ Vorhofflimmer-Episoden werden in der klinischen Routine häufig unterdiagnostiziert.

Role of the blood-derived coagulation factor Fibrinogen on Fibrotic Scaring in CNS disease

Scar formation is a common response to many central nervous system (CNS) disorders and a major obstacle blocking axonal regeneration in CNS disease. Previous work identified perivascular fibroblasts as a novel source of the “fibrotic” non-neural lesion scar in CNS disease. However, factors regulating fibrotic scar formation in CNS disease remain unknown. This study will identify the role of a changed environment in CNS disease with vasculature rupture and deposition of the circulating blood-derived coagulation factor fibrinogen on perivascular fibroblast activation and ECM deposition.

Investigating the bidirectional relationship between the gut microbiome and immunosuppressants: A step towards personalizing the immunosuppressive therapy of renal transplant recipients

Organ transplantation is made possible by the introduction of drugs, that suppress the immune system (immunosuppressants). They represent the cornerstone of modern transplant medicine. However, it is difficult to determine the right medication and immunosuppressive dose in advance of the transplantation, as every patient reacts differently to the treatment. As a result, frequent complications occur, which threaten transplant outcome and the patient’s health. Recently, intestinal bacteria (the microbiome) have been suspected to impact the efficacy and toxicity of immunosuppressive drugs.

CINAMOPS: Critical Illness Polyneuropathy and Myopathy: Outcome, Predictors and Longitudinal Trajectories

Critical Illness Polyneuropathy (CIP) and Myopathy (CIM) occur frequently as complications after severe illness where intensive care treatment was necessary. They present usually with a whole body muscle weakness which delays reconvalescence. Despite its high relevance, research is lacking regarding prognosis, course of the disease and therapy approaches. This cohort study addresses this research deficit and contributes to a better understanding of CIP/CIM and will therefore finally help to optimise care and treatment of affected patients.

Characterization of the pro-thrombotic activity of reticulated platelets in patients with coronary artery disease

The main purpose of this project is to investigate the detrimental role of a subgroup of platelets, called Reticulated platelets (RPs), in patients with coronary artery disease (CAD). RPs are young, hyper-reactive platelets with pro-thrombotic potential. High levels of RPs in peripheral blood are predictors of adverse events in different diseases including myocardial infarction. The reason of these correlations is still unclear, and the biology of RPs still has to be investigated.

Novel therapeutic directions to reduce thrombotic risk in patients with chronic kidney disease by targeting a pathological endothelium-platelet crosstalk

Patients with chronic kidney disease (CKD) experience both thrombotic and bleeding complications. Current therapy to reduce thrombotic risk focuses on antiplatelet drugs but increases bleeding risk. This calls for novel therapies addressing CKD-specific mechanisms of thrombosis with reduced impact on bleeding. Building on our expertise in inflamed vasculature as well as thrombus formation, we believe that this can be achieved with therapies tackling a pathological endothelium-platelet crosstalk in CKD.

Deciphering the epigenetic basis of nonalcoholic fatty liver disease with the help of a stem cell based in vitro model

About 20 - 30% of humans develop nonalcoholic fatty liver disease (NAFLD) as a response to a high caloric diet. It is associated with a loss of liver function which in the worst case necessitates liver transplantation. The disease is not fully understood and no medication is available. We want to study the role of epigenetics during disease development by analysing hepatocytes from healthy and diseased donors. Epigenetics sustainably influences gene expression. It helps to define cell types and is involved in the development of various diseases.

Cognition in Down’s Syndrome: Development, clinical symptoms and neuroanatomical correlates

Only a few studies exist on cognitive development across the life span of people with Down’s Syndrome (Trisomy 21). The main objective of this study is to investigate the cognitive functioning from childhood to older adult age and to examine differences to age-matched, typically developing controls. For this purpose we use neuropsychological tests, questionnaires concerning psychiatric disorders and symptoms of dementia, and magnetic resonance imaging (MRI).

Investigation of sodium channel Nav1.8 knock-out by CRISPR-Cas9 technology in human induced pluripotent stem cell cardiomyocytes

Heart failure is associated with arrhythmias and sudden cardiac death. Current data indicate that noncardiac sodium channel isoforms such as Nav1.8 lead to disruptions in cardiac electrophysiology. In order to investigate the importance of Nav1.8 and to show a link between Nav1.8-induced arrhythmia development, Nav1.8 knock-outs are generated in human, induced pluripotent stem cells using CRISPR-Cas9 technology and differentiated into cardiomyocytes.

Reconstruction of Lower Urinary Tract with vascularized "small intestinal submucosa" (BioVaSc-TERM®), Acronym: UroVasC

Applicants: PD Dr. sc. hum. Marco Metzger, Fraunhofer-Institut für Silicatforschung ISC, Translations-zentrum Regenerative Therapien, Würzburg
Dr. med. Frank-Mattias Schäfer, FEAPU, Abteilung für Kinderchirurgie und Kinderurologie Cnopfsche Kinderklinik, Nürnberg / Urologische und Kinderurologische Universitätsklinik des Uniklinikums Erlangen